KRONOX Stock Overview
Manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Kronox Lab Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹166.53 |
| 52 Week High | ₹200.50 |
| 52 Week Low | ₹138.14 |
| Beta | 0 |
| 11 Month Change | 5.33% |
| 3 Month Change | 6.20% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| KRONOX | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 2.4% | -0.8% | 0.5% |
| 1Y | n/a | 10.7% | 27.5% |
Return vs Industry: Insufficient data to determine how KRONOX performed against the Indian Chemicals industry.
Return vs Market: Insufficient data to determine how KRONOX performed against the Indian Market.
Price Volatility
| KRONOX volatility | |
|---|---|
| KRONOX Average Weekly Movement | 7.4% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: KRONOX has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine KRONOX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 57 | Jogindersingh Jaswal | www.kronoxlabsciences.com |
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents, such as ACS reagents, and LR, AR and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous. The company was incorporated in 2008 and is based in Vadodara, India.
Kronox Lab Sciences Limited Fundamentals Summary
| KRONOX fundamental statistics | |
|---|---|
| Market cap | ₹6.18b |
| Earnings (TTM) | ₹232.42m |
| Revenue (TTM) | ₹929.38m |
26.6x
P/E Ratio6.6x
P/S RatioIs KRONOX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KRONOX income statement (TTM) | |
|---|---|
| Revenue | ₹929.38m |
| Cost of Revenue | ₹465.15m |
| Gross Profit | ₹464.22m |
| Other Expenses | ₹231.80m |
| Earnings | ₹232.42m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.26 |
| Gross Margin | 49.95% |
| Net Profit Margin | 25.01% |
| Debt/Equity Ratio | 0% |
How did KRONOX perform over the long term?
See historical performance and comparison